A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma

BACKGROUND: E1694 tested GM2-KLH-QS21 vaccine versus high-dose interferon-α2b (HDI) as adjuvant therapy for operable stage IIB-III melanoma. We tested banked serum specimens from patients in the vaccine arm of E1694 for prognostic biomarkers. METHODS: Aushon Multiplex Platform was used to quantitate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarhini, Ahmad A, Lin, Yan, Yeku, Oladapo, LaFramboise, William A, Ashraf, Madeeha, Sander, Cindy, Kirkwood, John M, Lee, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909384/
https://www.ncbi.nlm.nih.gov/pubmed/24457057
http://dx.doi.org/10.1186/1479-5876-12-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909384/
https://www.ncbi.nlm.nih.gov/pubmed/24457057
http://dx.doi.org/10.1186/1479-5876-12-19

Ejemplares similares